It's time to complete your JBC Methods Madness bracket
Calling all scientists! Do you have a favorite method? Is there a biochemical technique you think has had monumental impacts on basic research and deserves a moment in the spotlight? The Journal of Biological Chemistry’s Methods Madness tournament is the chance you’ve been waiting for to voice your opinions. The person with the top-scoring bracket will win a $50 gift card.
How to participate
- Download and fill in your bracket. Use the editable PDF to make your predictions. Save your changes!
- Email your bracket to JBC. Double-check your entry, and then email it to methods@asbmb.org.
- Follow JBC on Twitter and vote for your favorite methods. The JBC Twitter handle is @JBiolChem. They'll be posting weekly polls. Don't forget to participate.
Visit the JBC Methods Madness website for the complete rules.
A note about JBC methods
It's well known that science progresses by building on the shoulders of those who came before. That's especially true for papers that report new tools — genetic constructs, small molecules, model organisms, etc. — that can be directly used by colleagues to jump-start a new project or resolve a technical hurdle. And at JBC, our high standards for rigor and reproducibility mean that readers can trust published tools to work as promised.
— Lila Gierasch, JBC editor-in-chief
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles
How sugars shape Marfan syndrome
Research from the University of Georgia shows that Marfan syndrome–associated fibrillin-1 mutations disrupt O glycosylation, revealing unexpected changes that may alter the protein's function in the extracellular matrix.
What’s in a diagnosis?
When Jessica Foglio’s son Ben was first diagnosed with cerebral palsy, the label didn’t feel right. Whole exome sequencing revealed a rare disorder called Salla disease. Now Jessica is building community and driving research for answers.
Peer through a window to the future of science
Aaron Hoskins of the University of Wisconsin–Madison and Sandra Gabelli of Merck, co-chairs of the 2026 ASBMB annual meeting, to be held March 7–10, explain how this gathering will inspire new ideas and drive progress in molecular life sciences.
Glow-based assay sheds light on disease-causing mutations
University of Michigan researchers create a way to screen protein structure changes caused by mutations that may lead to new rare disease therapeutics.
How signals shape DNA via gene regulation
A new chromatin isolation technique reveals how signaling pathways reshape DNA-bound proteins, offering insight into potential targets for precision therapies. Read more about this recent MCP paper.
A game changer in cancer kinase target profiling
A new phosphonate-tagging method improves kinase inhibitor profiling, revealing off-target effects and paving the way for safer, more precise cancer therapies tailored to individual patients. Read more about this recent MCP paper.